Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jan;19(1):1-10.
doi: 10.1097/FPC.0b013e3283163ecd.

Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response

Affiliations

Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response

Eric J Peters et al. Pharmacogenet Genomics. 2009 Jan.

Abstract

Several reports have been published investigating the relationship between common variants in serotonin-related candidate genes and antidepressant response, and most of the results have been equivocal. We previously reported a significant association between variants in serotonin-related genes and response to the selective serotonin reuptake inhibitor fluoxetine. Here, we attempt to expand upon and replicate these results by (i) resequencing the exonic and putatively regulatory regions of five serotonin-related candidate genes (HTR1A, HTR2A, TPH1, TPH2, and MAOA) in our fluoxetine-treated sample to uncover novel variants; (ii) selecting tagging single nucleotide polymorphisms (SNPs) for these genes from the resequencing data; and (iii) evaluating these tagging SNPs for association with response to the selective serotonin reuptake inhibitor citalopram in an independent sample of participants who are enrolled in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) clinical study (N=1953). None of the variants associated previously with fluoxetine response were found to be associated with citalopram response in the STAR*D sample set. Nor were any of the additional tagging SNPs found to be associated with citalopram response. An additional SNP in HTR2A (rs7997012), previously reported to be associated with outcome of citalopram treatment in this sample, but not well tagged by any of the other SNPs we studied, was also genotyped, and was associated with citalopram response (P=0.0002), strongly supporting the previous observation in the same STAR*D sample. Our results suggest that resequencing the serotonin-related genes did not identify any additional common SNPs that have not been identified previously. It appears that genetic variation in these five genes has a marginal effect on response to citalopram, although a previously observed association was supported and awaits replication in an independent sample.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Effect of minor allele frequency on tagging single nucleotide polymorphism (SNP) selection. The above histogram displays the number of SNPs (N=145 total) at each minor allele frequency bin (solid black bars). The striped bars indicate the number of SNPs, in each minor allele frequency bin, which were selected as tagSNPs using the method of Carlson et al. [18].
Fig. 2
Fig. 2
Accuracy of haplotype inference for three sets of tagging single nucleotide polymorphism (SNPs). Each of the eight haplotype blocks is shown on the x-axis. The minimum haplotype Rh2 value for all common haplotypes within each block, inferred using the tagSNP set, is shown on the y-axis. Three different methods for selection of tagSNPs are shown (see Methods). Owing to the fact that methods of Carlson et al. [18] and Ke and Cardon [21] do not output a unique set of tagSNPs, average (±SD) minimum Rh2 of all unique combinations of tagSNPs are shown.

References

    1. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617–627. - PMC - PubMed
    1. Serretti A, Benedetti F, Zanardi R, Smeraldi E. The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:1074–1084. - PubMed
    1. Kraft JB, Peters EJ, Slager SL, Jenkins GD, Reinalda MS, McGrath PJ, et al. Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample. Biol Psychiatry. 2007;61:734–742. - PubMed
    1. Smits KM, Smits LJ, Schouten JS, Stelma FF, Nelemans P, Prins MH. Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review. Mol Psychiatry. 2004;9:433–441. - PubMed
    1. Blier P, DE MC, Chaput Y. A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. J Clin Psychiatry. 1990;51(Suppl):14–20. - PubMed

Publication types

LinkOut - more resources